About Meredith Kotler
Meredith specializes in high-stakes litigation, including securities, M&A, and shareholder disputes. She represents multi-national companies, financial institutions, and their boards and management in significant securities class actions, having secured important dismissals in both federal and state courts. As major M&A transactions and board-level controversies continue to receive scrutiny, Meredith has defended companies, their management and boards, and their financial advisors in litigation relating to dozens of transactions with a cumulative value of over $150 billion in the last six years alone. She has also played a leading role in many matters raising novel corporate governance issues.
From 1998 to 2004, Meredith served as an Assistant US Attorney in the Southern District of New York, including as Deputy Chief Appellate Attorney. She often speaks on litigation panels, and her writings on the latest developments in Delaware courts and securities litigation have been published in the Harvard Law School Forum on Corporate Governance and other outlets.
Meredith’s recent representations include:
- 3M Company, several officers and directors in securities class action and related shareholder derivative suits based on alleged failure to disclose contingent environmental liabilities.
- AstraZeneca, its CEO, and several other executives in securities class action challenging statements regarding clinical trial of its COVID-19 vaccine.
- Tyson Foods and its officers and directors in securities class action alleging failure to disclose purportedly insufficient COVID-19 safety protocols at Tyson facilities.
- Energy Recovery in securities class action filed in connection with termination of licensing agreement.
- Apyx Medical and CEO in securities class action based on FDA denial of drug approval.
- Board of Directors of Ambac Financial in stockholder challenge to director compensation.
- SourceHOV in appeal to Delaware Supreme Court after adverse judgment in appraisal action before Delaware Chancery Court.
- Special Committee of Board of Directors of Emerald Holding in Delaware Chancery shareholder litigation challenging $400 million PIPE by controlling stockholder Onex Corporation.
Meredith received a J.D. degree, cum laude, from Harvard Law School in 1996 and an undergraduate degree, summa cum laude, from Princeton University in 1992. In 1997, she clerked for the Honorable Barbara S. Jones of the U.S. District Court for the Southern District of New York.
- October 28, 2021
“Navigating Responsible Board Oversight and Shareholder Demands for Books and Records”
The Society for Corporate Governance Fall Conference
- March 19, 2021
“A New Generation of Leaders in Securities Litigation and Regulatory Enforcement”
New York City Bar Association's 9th Annual Securities Litigation & Enforcement Institute
- January 29, 2021
“Delaware Litigation Developments” with The Hon. Morgan T. Zurn
PLI's Mergers & Acquisitions 2021: Advanced Trends & Developments
- January 29, 2020
“Developments in Securities Class Actions”
New York City Bar Association's 8th Annual Securities Litigation & Enforcement Institute
- January 10, 2020
“Delaware Litigation Developments” with The Hon. Kathaleen St. J. McCormick
PLI's Mergers & Acquisitions 2020: Advanced Trends & Developments
- March 24, 2019
“Litigation Update: Major Civil Cases”
SIFMA C&L 2019 Annual Seminar
- March 14, 2019
“Hot Topics in M&A Practice”
31st Tulane Corporate Law Institute
- February 20, 2019
“What do the latest directions at the Delaware Court of Chancery mean for the corporate law advice you will be giving and receiving?”
M&A, Antitrust, and the Board Room in 2019: Challenges and Conundrums for the West Coast
- January 11, 2019
“Mergers & Acquisitions 2019: Advanced Trends and Developments”
Practicing Law Institute